Ignite Creation Date:
2025-12-24 @ 3:26 PM
Ignite Modification Date:
2026-01-27 @ 9:40 AM
Study NCT ID:
NCT01320592
Status:
COMPLETED
Last Update Posted:
2020-04-08
First Post:
2011-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PD0332991/Paclitaxel in Advanced Breast Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Patient must have histologically or cytologically-confirmed metastatic | View |
| None | breast cancer | View |
| None | Any ER, PR or Her2 status is allowed. | View |
| None | Tumor must express Retinoblastoma (Rb) protein, defined as | View |
| None | any measurable staining by immunohistochemistry on the invasive tumor component | View |
| None | <3 prior cytoxic chemotherapy regimens for metastatic disease. | View |
| None | Performance status of 0-1 on the Eastern Cooperative Oncology Group … | View |
| None | Patient must have evaluable disease. Measureable disease is not required. | View |
| None | The subject has adequate organ function | View |